HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.1
  1. Home
  2. /Compound

Clofibric Acid

HCID 2797
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
882-09-7
Standard SMILES
CC(C)(Oc1ccc(Cl)cc1)C(=O)O
InChIKey
TXCGAZHTZHNUAI-UHFFFAOYSA-N
Molecular formula
C10H11ClO3
Average molar mass
214.64 g/mol
Monoisotopic mass
214.03967189

Overview

Clofibric acid is a monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate. It has a role as a herbicide, an antineoplastic agent, an antilipemic drug, an anticholesteremic drug, a PPARalpha agonist and a marine xenobiotic metabolite. It is a monocarboxylic acid, an aromatic ether and a member of monochlorobenzenes. It is functionally related to an isobutyric acid.

Names & identifiers

Preferred name
Clofibric Acid
IUPAC
2-(4-chlorophenoxy)-2-methylpropanoic acid
English name
2-(4-Chlorophenoxy)-2-methylpropionic acid
Molecular formula
C10H11ClO3
Molecular weight
214.65

Names & synonyms

clofibric acid882-09-72-(4-Chlorophenoxy)-2-methylpropanoic acid2-(4-CHLOROPHENOXY)-2-METHYLPROPIONIC ACIDChlorofibrinic acidClofibrinic acidChlorophibrinic acidChlorfibrinic acidClofibrate free acid2-(p-Chlorophenoxy)-2-methylpropionic acidClofibrinsaeure2-(p-Chlorophenoxy)isobutyric acid
Show more names
ClofibricPCIBPCPIB4-CPIBRegadrinClofibrinRegulipid
Acido clofibricoPropanoic acid, 2-(4-chlorophenoxy)-2-methyl-Acide clofibriquealpha-(p-Chlorophenoxy)isobutyric acidNSC-1149Acidum clofibricumNSC 1149p-Chlorophenoxyisobutyric Acid

Database identifiers

CAS
882-09-7
PubChem CID
2797
DTXSID
DTXSID1040661
ChEMBL

Properties

Computed structural propertiesFilling in

XLogP
2.6
Topological polar surface area
46.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
14
Formal charge
0
Complexity
207

Experimental & physicochemical properties

DrugsPharmaceuticals -> Antilipidemic Agents
LogP2.64
Ionization Efficiency · 6 items

Positive

-0.44

2.7

Agilent XCT

Electrospray ionization

formic acid (5.3nM)

Collision Cross Section · 2 items

146.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

149.4 Ų [M-H]-

Physicochemical properties

Melting point
120 · 120-122 °C(lit.)
Boiling point
308.11 °C · 308.11°C (rough estimate)
Density
1.2413 · 1.2413 (rough estimate)
refractive index
1.522 · 1.5220 (estimate)
storage temp.
Sealed in dry,Room Temperature
solubility
Chloroform, Methanol

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 47 reports by companies from 4 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
UE9455000
hs_code
29189900
risk_code
22-20/21/22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,Xi
safety_code
36-24/25
hazard_class
IRRITANT
Storage Class
11 - Combustible Solids
Hazard statements
H302
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P264-P270-P301+P312+P330-P501

Chemistry & industry

Pharmacology

Metabolism/MetabolitesClofibric acid has known human metabolites that include (2S,3S,4S,5R)-6-[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.
MeSH Pharmacological Classification · 2 items

Substances used to lower plasma CHOLESTEROL levels.

Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.

Applications · 4 items

DescriptionClofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 μM in a transactivation assay) and the active metabolite of clofibrate . It is formed from clofibrate by tissue and serum esterases. Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats. It decreases glutamate oxaloacetate transaminase (GOT) levels and increases glutamate pyruvate transaminase (GPT) and lactate dehydrogenase (LDH) levels, markers of xenobiotic stress, in the plasma of carp (C. carpio) when administered in tank water at a concentration of 10 μg/L. Clofibric acid has been found in wastewater effluent.

UsesAntilipemic.

Usesherbicide, antihyperlipoproteinemic, antineoplastic

UsesA hypolipidemic compound

Upstream & downstream products

Upstream raw materials

O-(4-chlorophenyl)hydroxylamineplafibrideChlorobutanol4-CHLOROPHENOL SODIUM SALTN-Acetyl-L-cysteine

Related reactions

52 records
New reaction record
HRID 114906 reaction equation
HRID 114906As reactantTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 125562 reaction equation
HRID 125562As reactantTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 201533 reaction equation
HRID 201533As reactantTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
HRID 323936 reaction equation
HRID 323936As reactantuspto-grants-2001_04
HRID 327623 reaction equation
HRID 327623As reactantuspto-grants-1993_12
HRID 327630 reaction equation
HRID 327630As reactantuspto-grants-1993_12
HRID 378596 reaction equation
HRID 378596As reactantuspto-grants-2000_02
HRID 437597 reaction equation
HRID 437597As reactantuspto-grants-1977_06
PreviousPage 1 of 7

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEMBL683
ChEBI
CHEBI:34648
UNII
53PF01Q249
EC Number
212-925-9
Nikkaji
J7.154D
form
Crystals or Crystalline Powder
pka
3.18 · 3.18±0.10(Predicted)
color
Pale yellow to brownish
Merck
14 · 14,2378
BRN
1874067 · 1874067
InChI
1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13)
InChIKey
TXCGAZHTZHNUAI-UHFFFAOYSA-N
SMILES
CC(C)(Oc1ccc(Cl)cc1)C(O)=O
CAS DataBase Reference
882 · 882-09-7(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
53 PF01Q249 · 53PF01Q249
NIST Chemistry Reference
Clofibric acid(882-09-7)
EPA Substance Registry System
2 · Propanoic acid, 2-(4-chlorophenoxy)-2-methyl- (882-09-7)
UNSPSC Code
77101502 · 77101502
NACRES
24 · NA.24
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
264 · P264-P270-P301+P312+P330-P501
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn,Xi
Risk Statements
22 · 22-20/21/22
Safety Statements
36 · 36-24/25
WGK Germany
3 · 3
RTECS
9455000 · UE9455000
HazardClass
IRRITANT
HS Code
29189900 · 29189900
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
4-Chlorophenol
Ethyl 2-bromoisobutyrate
Acetone
Chloroform
Acetamide

Downstream products

Clofibrateetofibrate 2-hydroxymethylnicotinateNicotinic acid

Additional notes

DefinitionChEBI: A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.